Gino Bernuzzi1, Federica Petraglia2, Martina Francesca Pedrini2, Massimo De Filippo3, Francesco Pogliacomi4, Michele Arcangelo Verdano4, Cosimo Costantino2. 1. Immunohaematology and Transfusion Centre, Department of Laboratory Medicine and Pathology, University Hospital of Parma, Parma, Italy. 2. Department of Clinical and Experimental Medicine, Unit of Sport and Functional Rehabilitation, University Hospital of Parma, Parma, Italy. 3. Department of Clinical Sciences, Section of Radiological Sciences, University Hospital of Parma, Parma, Italy. 4. Department of Surgical Sciences, Orthopaedic Department, University Hospital of Parma, Parma, Italy.
Abstract
BACKGROUND: Platelet-rich plasma is being used more frequently to promote healing of muscle injuries. The growth factors contained in platelet-rich plasma accelerate physiological healing processes and the use of these factors is simple and minimally invasive. The aim of this study was to demonstrate the efficacy of ultrasound-guided injection of platelet-rich plasma in muscle strains and the absence of side effects. MATERIALS AND METHODS: Fifty-three recreational athletes were enrolled in the study. The patients were recruited from the Emergency Room in the University Hospital at Parma according to a pre-defined protocol. Every patient was assessed by ultrasound imaging to evaluate the extent and degree of muscle injuries. Only grade II lesions were treated with three ultrasound-guided injections of autologous platelet-rich plasma every 7 days. Platelet concentrate was produced according to standard methods, with a 10% variability in platelet count. The platelet gel for clinical use was obtained by adding thrombin to the concentrates under standardised conditions. Outcomes assessed were: pain reduction, muscle function recovery and return to sports activity, ultrasound-imaging tissue healing, relapses, local infections, and any side effect during the treatment. RESULTS: In all cases muscle lesions healed fully on ultrasound-imaging, the pain disappeared, and muscle function recovery was documented with a return to sports activity. A single patient had a relapse 1 year after treatment. DISCUSSION: Platelet-rich plasma injected into the injury site is one of the most important factors rendering the treatment effective. To maximise its efficacy the preliminary ultrasound must be done accurately to localise the lesion and guide the needle into the corresponding lesion. According to the current results, which document full muscle recovery and no relapse except for one case, platelet-rich plasma ultrasound-guided injection represents a valid mini-invasive treatment for muscle injuries.
BACKGROUND: Platelet-rich plasma is being used more frequently to promote healing of muscle injuries. The growth factors contained in platelet-rich plasma accelerate physiological healing processes and the use of these factors is simple and minimally invasive. The aim of this study was to demonstrate the efficacy of ultrasound-guided injection of platelet-rich plasma in muscle strains and the absence of side effects. MATERIALS AND METHODS: Fifty-three recreational athletes were enrolled in the study. The patients were recruited from the Emergency Room in the University Hospital at Parma according to a pre-defined protocol. Every patient was assessed by ultrasound imaging to evaluate the extent and degree of muscle injuries. Only grade II lesions were treated with three ultrasound-guided injections of autologous platelet-rich plasma every 7 days. Platelet concentrate was produced according to standard methods, with a 10% variability in platelet count. The platelet gel for clinical use was obtained by adding thrombin to the concentrates under standardised conditions. Outcomes assessed were: pain reduction, muscle function recovery and return to sports activity, ultrasound-imaging tissue healing, relapses, local infections, and any side effect during the treatment. RESULTS: In all cases muscle lesions healed fully on ultrasound-imaging, the pain disappeared, and muscle function recovery was documented with a return to sports activity. A single patient had a relapse 1 year after treatment. DISCUSSION: Platelet-rich plasma injected into the injury site is one of the most important factors rendering the treatment effective. To maximise its efficacy the preliminary ultrasound must be done accurately to localise the lesion and guide the needle into the corresponding lesion. According to the current results, which document full muscle recovery and no relapse except for one case, platelet-rich plasma ultrasound-guided injection represents a valid mini-invasive treatment for muscle injuries.
Authors: Lars Engebretsen; Kathrin Steffen; Joseph Alsousou; Eduardo Anitua; Norbert Bachl; Roger Devilee; Peter Everts; Bruce Hamilton; Johnny Huard; Peter Jenoure; Francois Kelberine; Elizaveta Kon; Nicola Maffulli; Gordon Matheson; Omer Mei-Dan; Jacques Menetrey; Marc Philippon; Pietro Randelli; Patrick Schamasch; Martin Schwellnus; Alan Vernec; Geoffrey Verrall Journal: Br J Sports Med Date: 2010-12 Impact factor: 13.800
Authors: M Battaglia; F Guaraldi; F Vannini; T Buscio; R Buda; S Galletti; S Giannini Journal: Clin Exp Rheumatol Date: 2011-09-01 Impact factor: 4.473
Authors: Timothy E Foster; Brian L Puskas; Bert R Mandelbaum; Michael B Gerhardt; Scott A Rodeo Journal: Am J Sports Med Date: 2009-11 Impact factor: 6.202
Authors: Robert J de Vos; Adam Weir; Hans T M van Schie; Sita M A Bierma-Zeinstra; Jan A N Verhaar; Harrie Weinans; Johannes L Tol Journal: JAMA Date: 2010-01-13 Impact factor: 56.272
Authors: M Zappia; R Capasso; D Berritto; N Maggialetti; C Varelli; G D'Agosto; M T Martino; M Carbone; L Brunese Journal: Musculoskelet Surg Date: 2017-02-14
Authors: A Barile; F Bruno; S Mariani; F Arrigoni; A Reginelli; M De Filippo; M Zappia; A Splendiani; E Di Cesare; C Masciocchi Journal: Musculoskelet Surg Date: 2017-02-13
Authors: A Barile; F Bruno; S Mariani; F Arrigoni; L Brunese; M Zappia; A Splendiani; E Di Cesare; C Masciocchi Journal: Musculoskelet Surg Date: 2017-02-14
Authors: M De Filippo; A Pesce; A Barile; D Borgia; M Zappia; A Romano; F Pogliacomi; M Verdano; A Pellegrini; K Johnson Journal: Musculoskelet Surg Date: 2017-02-06
Authors: A Splendiani; F D'Orazio; L Patriarca; F Arrigoni; F Caranci; P Fonio; L Brunese; A Barile; E Di Cesare; C Masciocchi Journal: Musculoskelet Surg Date: 2017-02-06
Authors: Gustaaf Reurink; Gert Jan Goudswaard; Maarten H Moen; Adam Weir; Jan A N Verhaar; Johannes L Tol Journal: Sports Med Date: 2014-07 Impact factor: 11.136